BioCentury
ARTICLE | Company News

Novo Nordisk sales and marketing update

September 14, 2015 7:00 AM UTC

Germany’s Institute for Quality and Efficiency in Health Care (IQWiG) said in an early benefit assessment that “an additional benefit could not be documented” for Xultophy insulin degludec/liragluti...